Lp-PLA2 IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS IN DIALYZED PATIENTS

被引：0
|
作者：
De Mauri, Andreana [1 ,3 ]
Vidali, Matteo [4 ]
Rolla, Roberta [1 ,2 ]
Brustia, Maddalena [3 ]
David, Paola [3 ]
Ruva, Carlo [3 ]
Capurro, Federica [3 ]
Chiarinotti, Doriana [3 ]
Bellomo, Giorgio [1 ,2 ]
机构：
[1] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy
[2] Maggiore Carita Univ Hosp, Clin Chem Lab, Novara, Italy
[3] Maggiore Carita Univ Hosp, Nephrol & Dialysis Unit, Novara, Italy
[4] SS Trinita Hosp, Immunohematol & Transfus Med Unit, Borgomanero, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP742
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [31] A CORRELATION BETWEEN Lp-PLA2 AND MONOCYTE LEVELS IN ATHEROSCLEROSIS RISK SUBJECTS
    Kumboyono, K.
    Chomsy, I. N.
    Vijayadas, D.
    Wihastuti, T. A.
    INFEKTSIYA I IMMUNITET, 2022, 12 (06): : 1136 - 1142
  • [32] Lp-PLA2 (PLAC): Relationship to Conventional Risk Factors and Cardioprotective Drug Therapies in Coronary Patients
    Brinks, Jenna
    Franklin, Barry
    Fowler, Amy
    Boura, Judith
    Musialczyk, Maria
    Hardy, Roger
    Halley, Susan
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 333 - 334
  • [33] 4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk
    L. Lenzini
    B. Caroccia
    K. Antezza
    R. Wolfert
    R. Szczech
    M. Cesari
    K. Narkiewicz
    C. Williams
    G. Rossi
    High Blood Pressure & Cardiovascular Prevention, 2008, 15 (3) : 209 - 209
  • [34] Biological variability and specificity of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel marker of cardiovascular risk
    Wolfert, RL
    Kim, NW
    Selby, RG
    Sarno, MJ
    Warnick, RG
    Sudhir, K
    CIRCULATION, 2004, 110 (17) : 309 - 309
  • [35] Lp-PLA2 Inhibition-The Atherosclerosis Panacea?
    Karakas, Mahir
    Koenig, Wolfgang
    PHARMACEUTICALS, 2010, 3 (05): : 1360 - 1373
  • [36] Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2 and risk of coronary heart disease. Results from a large case-control study
    Khuseyinova, N.
    Rothenbacher, D.
    Hoffmann, M.
    Brenner, H.
    Koenig, W.
    EUROPEAN HEART JOURNAL, 2006, 27 : 129 - 129
  • [37] The role of carotid ultrasound, hs-CRP, and Lp-PLA2 in predicting cardiovascular events in low-risk young to middle-aged adults
    Barnhart, SI
    McHugh, VL
    Schaper, AM
    Mathiason, MA
    Perlock, PA
    Haider, TA
    Akosah, KO
    CIRCULATION, 2005, 111 (14) : E195 - E195
  • [38] Lp-PLA2: A New Target for Statin Therapy
    Braun, Lynne T.
    Davidson, Michael H.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 29 - 33
  • [39] Novel enzymatic method for assaying Lp-PLA2
    Yamaura, S.
    Sakasegawa, S.
    Ueda, S.
    Kayamori, Y.
    Sugimori, D.
    Karasawa, K.
    CLINICA CHIMICA ACTA, 2019, 493 : S190 - S191
  • [40] Lp-PLA2: A New Target for Statin Therapy
    Lynne T. Braun
    Michael H. Davidson
    Current Atherosclerosis Reports, 2010, 12 : 29 - 33
12345